Concepedia

Bernard Maillère

BM

Statistics

Publications

113

Citations

4.2K

H-Index

37

Active since

1990

Affiliations

Commissariat à l'Énergie Atomique et aux Énergies Alternatives(Current)

CEA Paris-Saclay

Inserm

Institut de Biologie et Technologies

Centre National de la Recherche Scientifique

Bernard Maillère is an author at Commissariat à l'Énergie Atomique et aux Énergies Alternatives specializing in immunology, life sciences, and t-cell epitopes.

ORCID

Publications per year

1990–2024

113

Publications

113

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy

Margitta Worm, Hae‐Hyuk Lee, Jörg Kleine‐Tebbe et al. · Journal of Allergy and Clinical Immunology · 2011 · 175 citations

, , +15

Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy

Michael Tarzi, Sven Klunker, Catherine Texier et al. · Clinical & Experimental Allergy · 2006 · 138 citations

, , +16

HLA-DR Restricted Peptide Candidates for Bee Venom Immunotherapy

Catherine Texier, Sandra Pouvelle, Marc Busson et al. · The Journal of Immunology · 2000 · 133 citations · Full text

, , +17

Assessment of Bet v 1-Specific CD4+ T Cell Responses in Allergic and Nonallergic Individuals Using MHC Class II Peptide Tetramers

Laurence Van Overtvelt, Erik Wambre, Bernard Maillère et al. · The Journal of Immunology · 2008 · 121 citations · Full text

, , +17

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

Hassane M. Zarour, Bernard Maillère, Vladimir Brusić et al. · PubMed · 2002 · 117 citations

, , +17

1–5 of 113